Brief: Opgen Subsidiary Curetis, FIND Sign Collaboration Agreement For Unyvero A30 RQ Platform
20/09/2022 14:13
Sept 20 (Reuters) - OpGen Inc OPGN.O :
* OPGEN SUBSIDIARY CURETIS AND FIND SIGN RESEARCH AND
DEVELOPMENT
COLLABORATION AGREEMENT FOR UNYVERO A30 RQ PLATFORM
* OPGEN INC - FEASIBILITY PHASE OF RESEARCH AND DEVELOPMENT
PROJECT SET TO CONCLUDE BY END OF Q1-2023 AND CO-FUNDED BY FIND
WITH EURO 700,000
Source text for Eikon: ID:nGNX2MLWqF
Further company coverage: OPGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CapForce
See all newsBrief: Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Brief: Opgen Inc - Received Nasdaq Notice That Co Is Not In Compliance With Minimum Stockholders' Equity Requirement For Continued Listing
Brief: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
Brief: OpGen Announces 1-For-10 Reverse Stock Split
Brief: David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing